We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Study Provides Global Analysis of COVID-19 Vaccines

News   Mar 19, 2021 | Original story from Novateur

 
New Study Provides Global Analysis of COVID-19 Vaccines

The twelve SARS-CoV-2 vaccine candidates reaching/announcing Phase III clinical trials by mid-November 2020. Shown in pie-chart configuration are the companies responsible for the development of the vaccines as well as their reported efficacy in Phase III trials. Credit: Novateur Ventures

 
 
Advertisement
 

RELATED ARTICLES

Improving the Quality and Safety of Heparin

News

A team has analyzed Heparin, the blood-thinning drug, using a new method to that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

READ MORE

CABYR Isoforms As Targets for Specific Immunotherapy

News

Calcium-binding tyrosine phosphorylation-regulated protein (CABYR) is considered a cancer testis protein. Researchers evaluate the CABYR isoforms: a/b and c mRNA expression in colorectal cancer to determine if these proteins hold promise as vaccine targets.

READ MORE

Targeting Therapeutics to Harmful Genes Using Nanoparticles

News

Chemical engineering researchers have created several different types of nanoparticles and analyzed them for the ability to deliver and protect siRNA-based therapeutics from the body's immune system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE